Journal of Advances in Medical and Pharmaceutical Sciences

Submit Manuscript


Subscription



Malaria and HIV Co-infection among COVID-19 Cohort in Selected Healthcare Facilities in Rivers State, Nigeria

Journal of Advances in Medical and Pharmaceutical Sciences, Page 42-48
DOI: 10.9734/jamps/2022/v24i630309

Abstract


Background: The COVID-19 pandemic began while improvement in malaria control and elimination had reached a peak. COVID-19 affected routine services particularly those for other killer infectious diseases including, HIV/AIDS and Malaria. This resulted in slowing progress in achieving control programs targets.


Aim: The study was aimed at evaluating malaria and HIV coinfection among COVID-19 cohort in selected healthcare facilities in Rivers State of Nigeria.


Methodology: The observational study showed a snapshot sampled only patients within the COVID-19 approved centers who consented to participate within the selected study area otherwise excluded. Simple random sampling technique was used to select 400 participants, giving subjects equal opportunity of participation. The majority of the data came from primary sources, but secondary sources were also used. Malaria testing was perform using microscopic method. Result outputs were presented on tables and charts.


Results: The study showed high prevalence of malaria infection among COVID-19 patients -327 (81.8%) but low rate of HIV co-infection- 2 (0.5%).


Conclusion: Much consideration should be channeled towards malaria endemicity and coinfection with COVID-19 unless it confers protective advantage as postulated by some studies however, a large scale and more in-depth study is suggested.

Keywords:
  • Malaria
  • HIV
  • co-infection
  • COVID-19
  • cohort

How to Cite

Nwalozie, R., Onosakponome, O. E., Hanson, A. H., & Nyebuchi, J. (2022). Malaria and HIV Co-infection among COVID-19 Cohort in Selected Healthcare Facilities in Rivers State, Nigeria. Journal of Advances in Medical and Pharmaceutical Sciences, 24(6), 42-48. https://doi.org/10.9734/jamps/2022/v24i630309

References

World Health Organization. HIV and AIDS Global health sector strategy on 2021, [accessed May 31 2022]; 2021.

Jordan RE, Adab P, Cheng KK. COVID-19 risk factors for severe disease and death. Br Med J. 2020;368:1198.

Goyal M, Baskonus HM, Prakash A. Regarding new positive, bounded and convergent numerical solution of nonlinear time fractional HIV/AIDS transmission model. Chaos Solitons & Fractals. 2020;139:0960-779.

DOI: 10.1016/j.chaos.2020.110096.

World Health Organization. World malaria report World Health Organization, Geneva [accessed Jun 1 2022]; 2020.

Center for Disease Control and Prevention. (Africa) test updates on the COVID-19 crisis from Africa CDC [cited Jun 1, 2022]; 2022.

Available: https://africacdc.org/covid-19/.

World Health Organization. Coronavirus disease. World Health Organization. Vol. 2019 (COVID-19): situation reports; 2019.

Available:https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.

Kuehn BM. COVID-19 rolls back progress against HIV, TB, and malaria. JAMA. 2021;326(15):1471.

DOI: 10.1001/jama.2021.18252, PMID 34665195.

Peter S. COVID-19 hit HIV, TB and malaria programs hard, We’re fighting back. Global fund; 2021 [cited Jun 6, 2022].

Available:https://www.theglobalfund.org/en/blog/2021-09-17-covid-19-hit-hiv-tb-and-malaria-programs-hard-we-re-fighting-back/Accessed.

Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020;20(7):773.

DOI: 10.1016/S1473-3099(20)30195-X, PMID 32171390.

Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020 May;20(5):533-4.

DOI: 10.1016/S1473-3099(20)30120-1, PMID 32087114.

Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20(6):669-77.

DOI: 10.1016/S1473-3099(20)30243-7, PMID 32240634.

Gilbert M, Pullano G, Pinotti F, Valdano E, Poletto C, Boëlle PY, et al. Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study. Lancet. 2020;395(10227):871-7.

DOI: 10.1016/S0140-6736(20)30411-6, PMID 32087820.

Nuwagira E, Muzoora C. Is Sub-Saharan Africa prepared for COVID-19? Trop Med Health. 2020;48(1):18.

DOI: 10.1186/s41182-020-00206-x, PMID 32288543.

Paintsil E. COVID-19 threatens health systems in sub-Saharan Africa: the eye of the crocodile. J Clin Invest. 2020;130(6):2741-4.

DOI: 10.1172/JCI138493, PMID 32224550.

Amimo F, Lambert B, Magit A. What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control? Trop Med Health. 2020;48:32.

DOI: 10.1186/s41182-020-00219-6, PMID 32425653.

Maze MJ, Bassat Q, Feasey NA, Mandomando I, Musicha P, Crump JA. The epidemiology of febrile illness in sub-Saharan Africa: implications for diagnosis and management. Clin Microbiol Infect. 2018;24(8):808-14.

DOI: 10.1016/j.cmi.2018.02.011, PMID 29454844.

Biambo KG, Nyebuchi J, Roseline E, Fyneface AC, Laurretta N. Zinc composition in breast milk of lactating mothers in urban and suburban areas in Rivers State. Asian J Res Nurs Health. 2021;4(4):165-9.

Catherine I, Biambo KG, Nyebuchi J, Fyneface AC, Goodnews N. Evaluation of nutrient composition in breast milk of breast feeding mothers in urban and sub-urban subjects in Rivers State. Asian J Pediatr Res. 2021;7(2):39-44.

DOI: 10.9734/ajpr/2021/v7i230213.

Cheesbrough M. District laboratory practice in tropical countries. 2nd ed. part 1. Cambridge: Cambridge University Press; 2010.

World Health Organization. Malaria. [accessed May 31 2022]; 2021b.

Anyanwu MU. The association between malaria prevalence and COVID-19 mortality. BMC Infect Dis. 2021;21(1):975.

DOI: 10.1186/s12879-021-06701-8, PMID 34538242.

Hoffmann M, Kleine-Weber H, Kruger N, Muller M, Drosten C, Pohlmann S. The novel coronavirus uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv; 2020.

Toombs J, M. Van den, Abbeele, K,Democratis, J., Merricks, R. In: 3 people living with HIV in the United Kingdom. J Med Virol COVID‐19. Mandal: Akj, Missouris C., G.; 2020.

Wu Q, Chen T, Zhang H. Recovery from COVID-19 in two patients with coexisted HIV infection. J Med Virol. 2020;92(11):2325-7.

DOI: 10.1002/jmv.26006, PMID 32401359.

Thirumalaisamy P. Velavan, Christian G. Meyer, Meral E, Peter G, Francine N. COVID-19 and syndemic challenges in ‘Battling the Big Three’: HIV, TB and malaria. International Journal of Infectious Diseases. 2021;106:29- 32.

Available:https://doi.org/10.1016/j.ijid.2021.03.071.

Vaughan A. COVID-19 could have disastrous impacts on HIV, TB and malaria. New Sci. 2020;247(3291): 8.

DOI: 10.1016/S0262-4079(20)31225-2, PMID 33518905.

Hellewell J, Abbott S, Gimma A, Bosse NI, Jarvis CI, Russell TW, et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health. 2020;8(4):e488-96.

DOI: 10.1016/S2214-109X(20)30074-7, PMID 32119825.
  • 43 times
    PDF Download: 31 times

Download Statistics

Make a Submission / Login
Information
Current Issue